COO of PDX Pharma served as a reviewer on the NIH Scientific Review Panel

Last week, Dr. Worapol Ngamcherdtrakul (COO) had the honor of serving as a reviewer on the NIH Scientific Review Panel for ‘Innovative Research in Cancer Nanotechnology’ and ‘Toward Translation of Nanotechnology Cancer Interventions’ R01 grants. We’re proud to contribute to groundbreaking advancements in cancer research.